1696 Share Price Performance
HK$0
-4.97 (-100.00%)
Price HK$0
Fair ValueHK$6.50
Share Pricen/a
Sisram Medical Ltd Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
1696 Community Narratives
AN
Fair Value
·Fair Value HK$6.5 60.8% undervalued intrinsic discount
AI Ecosystem And Injectables Expansion Will Support Long-Term Medical Aesthetics Leadership
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AI Ecosystem And Injectables Expansion Will Support Long-Term Medical Aesthetics Leadership
Catalysts About Sisram Medical Sisram Medical develops and commercializes integrated medical aesthetic solutions that combine energy based devices, injectables, AI driven diagnostics and personalized skincare into a single ecosystem. What are the underlying business or industry changes driving this perspective?Read more
AN
HK$6.5
60.8% undervalued intrinsic discount
Fair Value
Revenue
19.05% p.a.
Profit Margin
0.12%
Future PE
7.21x
Price in 2028
HK$0.078
Trending Discussion
Recently Updated Narratives
AN
AI Ecosystem And Injectables Expansion Will Support Long-Term Medical Aesthetics Leadership
Fair Value: HK$6.5 60.8% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Sisram Medical Ltd Key Details
About 1696
- Founded
- 1999
- Employees
- 1040
- CEO
- WebsiteView website
Sisram Medical Ltd, together with its subsidiaries, engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home-use devices, injectables, and cosmeceutical products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America. The company offers a portfolio of products and treatments for clinical aesthetic indications, including hair removal, skin rejuvenation, acne and acne scars, trans-epidermal delivery, face and body contouring, cellulite treatment, stretch marks, vascular and pigmented lesions, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue remodeling, injectables, personal care, aesthetic dentistry, hydradermabrasion, blepharoplasty (nonsurgical eyelid lift), liposuction, feminine health, and sexual rehabilitation. It also engages in pharmaceutical research and development activities. The company offers its products under the Alma, LMNT, Copulla, Profhilo, and Aliaxin brands. Sisram Medical Ltd was founded in 1999 and is headquartered in Caesarea, Israel.
